查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1549443

美國的磁振造影(MRI)系統市場評估:磁場強度，不同設計，各用途，各終端用戶，各地區，機會，預測(2017年～2031年)

United States Magnetic Resonance Imaging Systems Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 135 Pages | 商品交期: 3-5個工作天內

價格

美國磁振造影 (MRI) 系統市場規模預計將從 2023 年的 18.3 億美元增至 2031 年的 27.8 億美元，複合年增長率預計將成長 5.38%。

MRI系統市場預計將由美國主導，這主要是由於該國快速發展和創新友好的醫療基礎設施。 MRI 技術的進步正在加速美國和世界各地 MRI 系統市場的創新。影像品質和診斷準確性方面的新進展包括多參數成像、高場 MRI 掃描儀和人工智慧驅動的影像分析。此外，彌散張量造影（DTI）和功能性磁振造影（fMRI）的結合為研究大腦功能和連接性提供了新途徑，從而改善了神經系統疾病的診斷和治療。因此，老年人口的增加（更容易患神經系統疾病），加上 DTI 和 fMRI 技術的進步，預計將進一步推動 MRI 系統市場的成長。

此外，便攜式和緊湊型 MRI 系統的進步正在提高這些系統在偏遠地區的可及性和可用性。 Fujifilm Holdings Corporation 等全球領導者以及 Hyperfine, Inc. 和 Neuro42, Inc. 等新興市場公司繼續專注於開發緊湊型 MRI 系統。因此，技術進步和新產品推出推動了美國 MRI 系統市場的成長。例如，neuro42, Inc. 的用於神經影像應用的便攜式診斷 MRI 掃描儀於 2024 年 2 月獲得美國 FDA 510(k) 許可。該公司計劃於 2024 年某個時候在美國市場推出該系統。

MRI 意識的提高促進市場成長

由於安裝的 MRI 機器數量的增加，美國的磁振造影 (MRI) 系統市場正在擴大。由於人口老化、慢性病的增加以及準確及時診斷的需求推動了對先進診斷影像的需求，醫療機構正在大力投資 MRI 技術。現代 MRI 設備的升級功能，例如更快的掃描時間和更高解析度的影像，正在吸引醫療設施和診斷中心取代舊技術。這些發展使 MRI 服務變得更加廣泛且價格實惠，有助於治療更廣泛的疾病並改善患者的治療效果。此外，由於對非侵入性診斷方法的需求不斷增加以及人們對 MRI 在疾病早期診斷方面的益處的了解不斷增加，MRI 系統市場正在擴大。例如，南加州大學的研究人員在2023 年4 月進行的一項研究發表在《MDPI》（多學科數位出版研究所）雜誌上，發現許多門診影像模式都存在延遲，包括乳房X 光攝影、MRI 、CT 模式。由於 MRI 服務急劇下降，COVID-19 大流行對此後蓬勃發展的市場產生了重大影響。

老年人口成長推動市場成長

美國 MRI 系統市場的主要成長動力之一是人口老化。隨著人口老化，神經、關節和心血管疾病等與年齡相關的健康問題的盛行率也在增加。 MRI技術提供全面、非侵入性的影像，是診斷和治療許多複雜疾病的重要工具。老年人群更有可能患有慢性疾病並需要持續護理，這使得他們更有可能需要頻繁的診斷影像。因此，隨著人口老化，對先進診斷設備的需求增加，推動了美國MRI系統市場的成長。美國65歲及以上人口的比例預計將從2022年的17%上升到2050年的23%。此外，65歲及以上人口預計將從2022年的5,000萬增加到2050年的8,200萬，成長47%。

本報告研究和分析了美國磁振造影 (MRI) 系統市場，提供市場規模和預測、市場動態以及主要參與者的現狀和前景。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 美國的磁振造影(MRI)系統市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
    • 數量
  • 市場佔有率分析與預測
    • 磁場強度
    • 不同設計
    • 各用途
    • 各終端用戶
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2023年)
  • 市場地圖分析(2023年)
    • 磁場強度
    • 不同設計
    • 各用途
    • 各終端用戶
    • 各地區

第5章 供需分析

第6章 進口和出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

  • 推動市場要素
  • 市場課題

第12章 市場趨勢與發展

第13章 法規結構和革新

  • 法規當局的認證

第14章 專利形勢

第15章 案例研究

第16章 競爭情形

  • 市場領導者前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 主要企業前十大企業的形勢
    • GE Healthcare Technologies Inc.
    • Canon Medical Systems Corporation
    • Koninklijke Philips N.V.
    • Siemens Healthineers AG
    • Aurora Healthcare US Corp.
    • Fujifilm Holdings Corporation
    • Neusoft Medical Systems Co. Ltd.
    • Bruker Corporation
    • United Imaging Healthcare Co., Ltd.
    • Fonar Corporation

第17章 策略性推薦

第18章 本公司相關資料，免責聲明

Product Code: MX11874

United States magnetic resonance imaging (MRI) systems market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 1.83 billion in 2023 to USD 2.78 billion in 2031.

The MRI systems market is expected to dominate in the United States mainly because of its fast-paced development and innovation-friendly healthcare infrastructure. Innovation in the MRI systems market has accelerated in the United States as well as globally due to advancements in MRI technologies. New advancements in image quality and diagnostic precision include multi-parametric imaging, higher-field MRI scanners, and AI-driven image analysis. In addition, new avenues for studying brain function and connectivity have been made possible by the combination of diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI), which has improved neurological disease diagnosis and treatment. Thus, the rising geriatric population, which is more prone to developing neurological disorders coupled with advancements in DTI and fMRI technologies, is expected further to fuel the growth of MRI systems in the market.

Furthermore, advancements in portable and compact MRI systems have improved the access and availability of these systems in remote areas. Global leaders, such as Fujifilm Holdings Corporation, and emerging market players, such as Hyperfine, Inc., and neuro42, Inc., continuously focus on developing compact MRI systems. Thus, technological advancements and new product launches will accelerate the growth of the United States MRI systems market. For instance, in February 2024, neuro42, Inc. received US FDA 510(k) clearance for its portable diagnostic MRI scanner for neuroimaging applications. The company is planning to launch this system in the US market during year 2024.

Rising Awareness About MRIs Drive Market Growth

The magnetic resonance imaging (MRI) systems market in the United States is expanding due to the growing installation of MRI machines. Healthcare facilities are heavily investing in MRI technology as demand for advanced diagnostic imaging is rising due to an aging population, an increase in chronic diseases, and the need for accurate and timely diagnosis. The upgraded features of contemporary MRI machines, such as faster scanning periods and higher resolution images, are drawing medical facilities and diagnostic centers to replace their outdated technology. These developments make MRI services more widely available and reasonably priced, treating a wider spectrum of illnesses and enhancing patient outcomes. In addition, the MRI systems market is expanding due to rising demand for non-invasive diagnostic methods and growing knowledge of the advantages of MRI in early disease diagnosis. For example, a study conducted in April 2023 and published in the Multidisciplinary Digital Publishing Institute (MDPI) journal by researchers at the University of Southern California found that delays were observed in many imaging modalities in the outpatient setting, with the modalities of mammography, MRI, and CT showing the largest decreases with over 12,000 imaging delays. Due to the sharp decline in MRI services, the COVID-19 pandemic thus had a major effect on the market and has only flourished ever since then.

Rising Geriatric Population Boosts Market Growth

One major factor propelling the growth of the MRI systems market in the United States is the aging population. The prevalence of age-related health concerns, including neurological illnesses, joint problems, and cardiovascular conditions, is rising along with the elderly population. With its comprehensive and non-invasive imaging capabilities, MRI technology is a vital tool in the diagnosis and treatment of many intricate disorders. Since they are more likely to have chronic illnesses and need ongoing care, older persons are more likely to need frequent diagnostic imaging. Thus, in turn, the aging population is driving an increased demand for advanced diagnostic instruments, which is driving the growth of the MRI systems market in the United States. The population share of the United States, which constitutes people aged 65 and above, is projected to rise from 17% in 2022 to 23% by 2050. Moreover, the number of people aged 65 and above is expected to rise from 50 million in 2022 to 82 million in 2050, showcasing a hike of 47%.

Dominance of High Field Strength MRI Segment in the United State MRI Systems Market

The magnetic resonance imaging (MRI) systems market in the United States is expanding at a substantial rate due to the introduction of high-field strength (HF) and ultra-high field strength (UH) MRI systems. Compared to conventional 1.5T MRI machines, HF MRI systems, which commonly operate at 3 Tesla (T), and UH MRI systems, which operate at 7T and beyond, offer improved imaging capabilities. These cutting-edge devices enable earlier and more accurate diagnosis of a variety of illnesses by improving image contrast, resolution, and detail. Since high-field strength MRI systems can record fine anatomical and physiological features, which are essential for diagnosing complicated neurological, musculoskeletal, and cardiovascular problems, they are gaining increasing traction and widespread adoption. For instance, in March 2024, Siemens Healthineers AG announced the launch of MAGNETOM Terra.X. This second-generation clinical 7-tesla magnetic resonance imaging scanner significantly improves 7T MR scanning capabilities with new hardware and XA60A software, which has also received FDA certification. The MAGNETOM Terra, which made its debut in 2017 as the first 7T clinical MR scanner in the world and allowed incredibly high-resolution imaging, is now replaced by the MAGNETOM Terra.X.

Neurology Segment Dominates United States Magnetic Resonance Imaging (MRI) Systems Market

MRI systems are utilized to obtain fine-grained images of the bones, organs, tissues, and nerves in the body. MRI is used to diagnose several conditions, including stroke, traumatic brain injury, brain and spinal cord tumors, inflammation, infection, vascular abnormalities, brain damage connected to epilepsy, abnormally formed brain regions, and other neurodegenerative illnesses. Due to the growing use of MRI imaging in the diagnosis of neurological diseases and the development of sophisticated MRI equipment for neurology, the neurology segment of the market is anticipated to rise significantly. Additionally, it is anticipated that the rise in neurological conditions like dementia and Alzheimer's disease will increase demand for MRI machines in the US, which will support the market's expansion throughout the projected period. For instance, the Alzheimer's Disease Facts and Figures study estimated that 6.7 million Americans, 65 years of age and older, were diagnosed with Alzheimer's dementia in 2023. Furthermore, it is anticipated that by 2050, 12.7 million of the population would be suffering from dementia in the United States.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the United States magnetic resonance imaging (MRI) systems market are the rising numbers of chronic ailments, the increasing prevalence of diseases, and thus, the rising requirement to conduct diagnostic tests. However, the growing need to have precision medicine to maintain a healthy population is also going to fuel the MRI Systems market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, in October 2023, Koninklijke Philips N.V. announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.

Key Players Landscape and Outlook

The United States MRI systems market is a consolidated market with the majority of the share held by global leaders, including GE Healthcare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and Canon Inc. These players are complying with new strategic initiatives regarding the launches of newly developed magnetic resonance imaging techniques to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For example, in September 2023, an agreement in the field of MRI was signed by Subtle Medical, Inc., an artificial intelligence (AI)-powered image acquisition solution provider, and Bracco Imaging S.p.A., a manufacturer of diagnostic imaging components. These international collaborations were anticipated to start in the United States, where Bracco Imaging most likely uses Bracco Diagnostics Inc., a subsidiary, to distribute its line of goods and services.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Magnetic Resonance Imaging (MRI) Systems Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Field Strength
      • 4.2.1.1. Low
      • 4.2.1.2. Medium
      • 4.2.1.3. High
      • 4.2.1.4. Ultra-High
    • 4.2.2. By Design
      • 4.2.2.1. Open MRI
      • 4.2.2.2. Traditional MRI
      • 4.2.2.3. Wide Bore MRI
    • 4.2.3. By Application
      • 4.2.3.1. Cardiology
      • 4.2.3.2. Oncology
      • 4.2.3.3. Neurology
      • 4.2.3.4. Musculoskeletal
      • 4.2.3.5. Orthopedic
      • 4.2.3.6. Gastroenterology
      • 4.2.3.7. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Diagnostic and Imaging Centers
      • 4.2.4.3. Ambulatory Surgical Centers
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. Northeast
      • 4.2.5.2. Midwest
      • 4.2.5.3. West
      • 4.2.5.4. South
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Field Strength
    • 4.3.2. By Design
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. GE Healthcare Technologies Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 16.3.2. Canon Medical Systems Corporation
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Aurora Healthcare US Corp.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Neusoft Medical Systems Co. Ltd.
    • 16.3.8. Bruker Corporation
    • 16.3.9. United Imaging Healthcare Co., Ltd.
    • 16.3.10. Fonar Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Magnetic Resonance Imaging Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. United States Magnetic Resonance Imaging Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. United States Magnetic Resonance Imaging Systems Market Share (%), By Field Strength, 2017-2031F
  • Figure 4. United States Magnetic Resonance Imaging Systems Market Share (%), By Design, 2017-2031F
  • Figure 5. United States Magnetic Resonance Imaging Systems Market Share (%), By Application, 2017-2031F
  • Figure 6. United States Magnetic Resonance Imaging Systems Market Share (%), By End-user, 2017-2031F
  • Figure 7. United States Magnetic Resonance Imaging Systems Market Share (%), By Region, 2017-2031F
  • Figure 8. By Field Strength Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 9. By Design Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 10. By Application Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 11. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 12. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023